Overview
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Lobbying Costs
None declared
Financial year: Jan 2022 - Dec 2022
Lobbyists (Full time equivalent)
0.25 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Avicenna Alliance (Avicenna)
EU Transparency Register
645734991688-05 First registered on 02 Apr 2024
Goals / Remit
The Avicenna Alliance is a global non-profit organization bringing together health care stakeholders with the goal of making in silico medicine standard practice in health care through a collaborative ecosystem of patients, clinicians, academics, industries, policy makers, regulators & payers.
The Avicenna Alliance seeks to significantly accelerate medical innovation and its practical implementation, to ensure safe, affordable and cost-effective healthcare through the large-scale adoption of in silico medicine and by making in silico medicine a standard practice in healthcare. The Alliance’s objectives include:
• Ensure a forward-looking policy framework to facilitate the large-scale development and acceptance of in silico medicine
• Work on developing international guidelines and standards for in silico methods such as a Good Simulation Practice document
• Bridge the gap between basic research and the commercialisation of products by exploring areas of mutual cooperation and benefitsMain EU files targeted
• Proposal for a regulation on a European Health Data Space
• Europe’s Beating Cancer Plan
• Regulation on a European approach for Artificial Intelligence
• New Coordinated Plan on Artificial Intelligence
• Proposal for a regulation on the European Health Emergency Preparedness and Response Authority (HERA)
• Regulation on serious cross-border threats to health
• Proposal for a Regulation on a reinforced role of the EMA
• Council Regulation on establishing the new European High Performance Computing Joint Undertaking
• Pharmaceutical Strategy
o Revision of EU rules on medicines for children and rare diseases
o Revision of the EU general pharmaceuticals legislationAddress
Head Office
Rue Guimard 10
Bruxelles 1040
BELGIUMEU Office
Rue Guimard 10
Bruxelles 1040
BELGIUMWebsite
-
People
Total lobbyists declared
1
Employment time Lobbyists 25% 1 Lobbyists (Full time equivalent)
0.25
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Non-governmental organisations, platforms and networks and similar
-
Networking
Affiliation
https://www.avicenna-alliance.com/partners.html
Member organisations
https://www.avicenna-alliance.com/members.html
-
Financial Data
Interests represented
Does not represent commercial interests
Closed financial year
Jan 2022 - Dec 2022
Lobbying costs for closed financial year
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Total organisational budget in closed year
314,500€
Major funding types in closed year
Member's contributions
Major contributions in closed year
None declared
Other financial info
None declared
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
N/A
Communication activities
Meetings with MEPs involved in Digital Health
Publication of meetings and achievement on social media and web pageOther activities
None declared
- Meetings
Meetings
None declared
- Meetings